Thus, P1 subgroup included a majority of tumour samples classified as CCS1 subtype,5 characterized by KRAS and/or TP53 mutations and corresponding to the group of chromosomal‐instable (CIN) tumours. This evidence concerns the gene KRAS and neoplasm.